Patents Assigned to Her Majesty the Queen in right of Canada, as represented by the National Research Council
  • Patent number: 5883244
    Abstract: The present invention relates to recombinant .beta.-1,3-glucanase essentially free of proteases. The enzyme is obtained through the use of a recombinant DNA expression vector which comprises a DNA sequence encoding the .beta.-1,3-glucanase gene or mutants and variants thereof placed under the control of an exogenous expression promoter, preferably a bacterial promoter. Also, the .beta.-1,3-glucanase gene may include sequences flanking the open reading frame of the native .beta.-1,3-glucanase gene. The present invention also relates to a microorganism transformed with a recombinant DNA expression vector comprising the .beta.-1,3-glucanase gene or mutants and variants thereof under the control of an exogenous expression promoter.
    Type: Grant
    Filed: June 29, 1993
    Date of Patent: March 16, 1999
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Shi-Hsiang Shen, Pierre Chretien, Lison Bastien, Steve N. Slilaty
  • Patent number: 5523211
    Abstract: A process for identifying proteinaceous protoxins expressed by Bacillus thuringiensis genes is disclosed. According to the process, daughter toxins are first generated by subjecting a protoxin-containing material, such as parasporal crystals of Bacillus thuringiensis, to limited proteolysis with a proteolytic enzyme in an aqueous suspension having a pH above 9.5. The daughter toxins are then separated by high performance anion-exchange liquid chromatography at a constant pH in excess of 10 in an increasing gradient of a salt, preferably sodium chloride. The gradient conditions, which are specific for the column used, are achieved by employing a series of buffers having increasing concentration of the salt and introduced at a predetermined time and rate. The procedure provides a chromatogram showing clearly identifiable peaks of toxins and permits therefore the qualitative and quantitative characterization of the original mixture and isolation of the individual toxins.
    Type: Grant
    Filed: July 19, 1994
    Date of Patent: June 4, 1996
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Marianne Pusztai-Carey, Paul R. Carey, Timothy Lessard, Makoto Yaguchi
  • Patent number: 5356788
    Abstract: A process for identifying proteinaceous protoxins expressed by Bacillus thuringiensis genes is disclosed. According to the process, daughter toxins are first generated by subjecting a protoxin-containing material, such as parasporal crystals of Bacillus thuringiensis, to limited proteolysis with a proteolytic enzyme in an aqueous suspension having a pH above 9.5. The daughter toxins are then separated by high performance anion-exchange liquid chromatography at a constant pH in excess of 10 in an increasing gradient of a salt, preferably sodium chloride. The gradient conditions, which are specific for the column used, are achieved by employing a series of buffers having increasing concentration of the salt and introduced at a predetermined time and rate. The procedure provides a chromatogram showing clearly identifiable peaks of toxins and permits therefore the qualitative and quantitative characterization of the original mixture and isolation of the individual toxins.
    Type: Grant
    Filed: August 5, 1993
    Date of Patent: October 18, 1994
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Paul R. Carey, Timothy Lessard, Makoto Yaguchi, Marianne Pusztai
  • Patent number: 5338679
    Abstract: Disclosed is a recombinant vertebrate F such as vaccinia virus which comprises in its genome (i) spheroidin promoter of entomopoxvirus such as Choristoneura biennis and (ii) at least one structural gene coding for at least one protein foreign to entomopoxvirus and to the vertebrate poxvirus and is capable of expressing the foreign protein gene in a vertebrate tissue culture cell or in a vertebrate animal susceptible to the vaccinia virus. The recombinant virus is capable of expressing the foreign gene at a significantly higher rate due to the presence of the entomopoxvirus spheroidin promoter than the same virus without the entomopoxvirus promoter. The protein may be antigenic or otherwise pharmaceutically useful. Also disclosed vaccine and a process for producing the protein using the recombinant virus.
    Type: Grant
    Filed: January 8, 1991
    Date of Patent: August 16, 1994
    Assignee: Her Majesty the Queen in right of Canada, as represented by National Research Council Canada and Forestry Canada
    Inventors: Kai-Chung L. Yuen, Basil Arif
  • Patent number: 5288613
    Abstract: The present invention relates to a method for determining the degree of freshness of raw, frozen and processed edible fish by monitoring the degradation of adenine triphosphate to inosine monophosphate, inosine and hypoxanthine. This method comprises simultaneously determining, by use of a suitable amperometric electrode such as platinum vs. silver/silver chloride polarized at 0.7 V, the amount of uric acid and hydrogen peroxide resulting from the degradation of hypoxanthine by xanthine oxidase, the degradation of inosine by the combined action of nucleoside phosphorylase and xanthine oxidase and the degradation of inosine monophosphate by the combined action of nucleotidase, nucleoside phosphorylase and xanthine oxidase. Also within the scope of this invention is a method for the immobilization of nucleotidase on the walls of a polymeric tube such as polystyrene tube and the co-immobilization of nucleoside phosphorylase and xanthine oxidase on a porous polymeric membrane such as a nylon membrane.
    Type: Grant
    Filed: December 5, 1991
    Date of Patent: February 22, 1994
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: John H. T. Luong, Keith B. Male, An L. Nguyen
  • Patent number: 5201931
    Abstract: Composition for enhancing germination and growth of plants which comprises an effective amount of at least one abscisic acid-related compound having the following formula (I): ##STR1##
    Type: Grant
    Filed: December 1, 1989
    Date of Patent: April 13, 1993
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Suzanne R. Abrams, Lawrence V. Gusta
  • Patent number: 5180665
    Abstract: The present invention relates to a method for quantitatively assaying the presence of DSP toxins such as okadaic acid and dinophysistoxin-1 in marine samples. The method comprises the steps of preparing a marine extract, fractionating the prepared marine extract and selecting the extract fraction containing the toxin to be assayed. Once the desired extract fraction has been selected, a labelled substrate for protein phosphatase and at least one protein phosphatase are added to the extract in an assay. The amount of toxin present is quantitatively measured by the ability of the extract fraction to inhibit catalysis, mainly dephosphorylation, of the labelled substrate by protein phosphatases, such as phosphatase-1 (PP1) or phosphatase-2A (PP2A). Preferably, the method of the present invention is used to assay the presence of okadaic acid in marine organisms such as mussels, oysters, scallops, phytoplankton and the like.
    Type: Grant
    Filed: November 21, 1990
    Date of Patent: January 19, 1993
    Assignee: Her Majesty the Queen in right of Canada, as represented by The National Research Council of Canada
    Inventor: Charles Holmes
  • Patent number: 5116313
    Abstract: An apparatus for injecting liquids into a body without using hypodermic needles, the liquid being ejected from a small orifice in a probe at a velocity which will penetrate the surface of a body against which the probe is placed. The apparatus ejects a specific small volume of the liquid under a very high initial velocity and pressure followed by the ejection of the main charge of liquid at a lower velocity so that the liquid flows into the channel caused by the initial penetration without penetrating to a greater depth. The probe is connected to a hand-held portion whose other end is attached via a flexible tube containing a suitable hydraulic fluid to two remote pressure intensifiers, one of which creates the required high initial pressure for a short period of time and the other of which provides the pressure necessary to eject the main charge of liquid at a lower velocity.
    Type: Grant
    Filed: August 31, 1990
    Date of Patent: May 26, 1992
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council
    Inventor: Gavin McGregor
  • Patent number: 5071743
    Abstract: The present invention relates to an approach for conducting site-directed mutagenesis using double-stranded DNA templates. The approach involves the development of a method for generating structures capable of directing full-length complementary-strand synthesis from double-stranded plasmid DNA. These structures are formed following heat denaturation and cooling of linearized plasmid DNA molecules in the presence of what is referred to as a "closing oligonucleotide". A "closing oligonucleotide" is a single-stranded oligonucleotide consisting of a sequence complementary to either or both free ends of one of the two plasmid DNA strands. The "closing oligonucleotide" therefore functions as an agent for recircularization of a DNA strand and generation of a primer-circular template structure suitable for polymerase-dependent full-length complementary-strand synthesis and ligation into a covalently-closed heteroduplex DNA molecule.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: December 10, 1991
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Steve N. Slilaty, Shi-hsiang Shen, Susan Lebel
  • Patent number: 5037758
    Abstract: A B. subtilis strain possessing an enhanced surfactin production potential. The strain is a mutant of B. subtilis ATCC 21332 and has at least one mutation between Arg4 and HisA1 sites of the genetic map of B. subtilis ATCC 21332. Also included in the present invention is B. subtilis strain having the identifying characteristics of ATCC 53813.
    Type: Grant
    Filed: January 11, 1989
    Date of Patent: August 6, 1991
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Catherine N. Mulligan, Terry Y. Chow
  • Patent number: 5010006
    Abstract: A dry porous macromolecular matrix is prepared comprising a cross-linked mixture of 69.9 to 86.6% by weight of an inert protein 0.4 to 10.2% by weight of a lipase enzyme and about 11.7 to 23% by weight of a cross-linking agent. The matrix is prepared by reacting the lipase, inert protein and cross-linking agent in a buffer solution, freezing the resulting reacted mixture at a temperature ranging between -20.degree. C. and -195.degree. C., allowing the frozen mixture to thaw to a temperature ranging from 4.degree. C. to 25.degree. C., and rinsing and drying the resulting product at room temperature.
    Type: Grant
    Filed: August 11, 1988
    Date of Patent: April 23, 1991
    Assignee: Her Majesty the Queen in Right of Canada as represented by the National Research Council of Canada
    Inventors: Francoise Ergan, Michael Trani, Gerald Andre
  • Patent number: 4950833
    Abstract: The present invention relates to a process for the reductive dehalogenation of polyhaloaromatic compounds. It comprises reacting polyhaloaromatics in a hydrocarbon or silicone-based oil or an organic diluent, with an alkali metal in the presence of an ammonium salt to reduce the polyhaloaromatics to hydrogenated aromatics and to convert the halogen content to metal halides. Preferably, the polyhaloaromatics and the ammonium salt are to be reacted with the alkali metal in the form of a suspension. Other preferred features include the use of an amount of alkali metal ranging from 5 to 10 moles and the use of an amount of ammonium salt also ranging from 5 to 10 moles for each mole of the polyhaloaromatic compound to be reduced, carrying out the reaction under an inert atmosphere and carrying out the reaction at a temperature ranging from 40.degree. to 60.degree. C.
    Type: Grant
    Filed: September 28, 1989
    Date of Patent: August 21, 1990
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Jalal A. Hawari, Rejean Samson